Author(s): Torres, T ; Ferreira, A ; Ferreira, P ; Henriques, M ; Leite, L ; Magina, S ; Marques Pinto, G ; Oliveira, H ; Sousa Basto, A ; Tavares Bello, R ; Varela, P ; Massa, A ; Selores, M ; Filipe, P
Date: 2016
Persistent ID: http://hdl.handle.net/10400.26/17366
Origin: Saúde - CUF
Subject(s): Agentes Biológicos; Medicamentos Biossimilares; Psoríase/tratamento; Biological Agents; Biosimilar Pharmaceuticals; Psoriasis/drug therapy; Portugal
